<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">345716</id>
  <title nil="true"/>
  <common-name>3-[3-(1h-benzimidazol-2-yl)phenyl]-6,8-dibromo-2-phenylquinazolin-4-one</common-name>
  <description>3-[3-(1h-benzimidazol-2-yl)phenyl]-6,8-dibromo-2-phenylquinazolin-4-one is a chemical compound with the formula C27H16Br2N4O. With an average molecular weight of 572.20 g/mol, 3-[3-(1h-benzimidazol-2-yl)phenyl]-6,8-dibromo-2-phenylquinazolin-4-one is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>63583</pubchem-id>
  <chemical-formula>C27H16Br2N4O</chemical-formula>
  <weight>572.2</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T08:41:00Z</created-at>
  <updated-at type="dateTime">2026-08-31T08:41:00Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1=CC=C(C=C1)C2=NC3=C(C=C(C=C3Br)Br)C(=O)N2C4=CC=CC(=C4)C5=NC6=CC=CC=C6N5</moldb-smiles>
  <moldb-formula>C27H16Br2N4O</moldb-formula>
  <moldb-inchi>InChI=1S/C27H16Br2N4O/c28-18-14-20-24(21(29)15-18)32-26(16-7-2-1-3-8-16)33(27(20)34)19-10-6-9-17(13-19)25-30-22-11-4-5-12-23(22)31-25/h1-15H,(H,30,31)</moldb-inchi>
  <moldb-inchikey>SGMYIEDYULORQO-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">569.96909</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>6.7</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM341609</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>3-[3-(1h-benzimidazol-2-yl)phenyl]-6,8-dibromo-2-phenylquinazolin-4-one</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Benzimidazoles</klass>
  <subklass>Phenylbenzimidazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0296072</sync-id>
  <structure-inchikey>SGMYIEDYULORQO-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>100000000000000080000000000000200020000000040000020000001000000002104000000000000000000400000200080000001000000010000000000000000000020000000000000000000808000000000000000000080004000000000100000000400000100000000000000000000000001004000000000804000200000000000800000000100000000000000000000000000000000000000040000080000000000000004020000000000000000000000040000000000002040000100000000800000000000002820004200040001000000080040000001000040000000000000080000000000000040000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAiAAAAJwAAAIABBkBoAAAAAwMBBkBoAAAA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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:44:40Z</structure-indexed-at>
</compound>
